01Oct 2023
Targeting Pulmonary Fibrosis by SLC1A5-Dependent Glutamine Transport Blockade

Targeting Pulmonary Fibrosis by SLC1A5-Dependent Glutamine Transport Blockade

This study reveals that TGF-β-induced myofibroblast activation relies on the metabolic maladaptation of the solute carrier SLC1A5, responsible for cellular glutamine uptake. Fibrotic lung fibroblasts and those from idiopathic pulmonary fibrosis lungs exhibit heightened SLC1A5 expression. Inhibiting SLC1A5 disrupts fibroblast activation, impacting autophagy, mTOR, HIF, Myc signaling, and cellular energetics.

  • #pulmonology

Like

Save

Share